Canbridge Pharmaceuticals Inc
HKEX:1228
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Canbridge Pharmaceuticals Inc
HKEX:1228
|
CN |
|
Damodar Industries Ltd
NSE:DAMODARIND
|
IN |
|
A
|
Agilyx ASA
OSE:AGLX
|
NO |
|
A
|
Atlas Global Brands Inc
CNSX:ATL
|
CA |
|
C
|
CEL-SCI Corp
AMEX:CVM
|
US |
|
Z
|
Zehnder Group AG
SWB:ZEH2
|
CH |
|
S
|
Shanghai MicroPort MedBot Group Co Ltd
HKEX:2252
|
CN |
|
S
|
Sierra Bancorp
NASDAQ:BSRR
|
US |
|
Mitsui E&S Holdings Co Ltd
TSE:7003
|
JP |
|
Orexo AB
STO:ORX
|
SE |
Dividends
Dividend Yield
Canbridge Pharmaceuticals Inc
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Canbridge Pharmaceuticals Inc
Payout Ratio
Canbridge Pharmaceuticals Inc
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Canbridge Pharmaceuticals Inc is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Canbridge Pharmaceuticals Inc
| Average Annual Return | -55.83% |
| Standard Deviation of Annual Returns | 34.38% |
| Max Drawdown | -99% |
| Market Capitalization | 1.3B HKD |
| Shares Outstanding | 511 250 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Canbridge Pharmaceuticals Inc's latest stock split occurred on Oct 23, 2009
The company executed a 1-for-10 stock split, meaning that for every 10 shares held, investors received 1 new share.
The adjusted shares began trading on Oct 23, 2009. This was Canbridge Pharmaceuticals Inc's 2nd stock split, following the previous one in Oct 11, 2007.
